Therefore, we concluded that the IFI27, TUBB2A and the pathways of NET formation and lupus like immune profile may be the potential immune deregulation mechanism triggered by COVID-19, but further experimental validation in vitro and in vivo is needed. This evidence concerns the gene TUBB2A and COVID-19.